 |
|
|
 Hot Stock to Watch |
Company: Terra Tech Corp (OTCQB: TRTC)
|
Last:
Price: 0.2449
Change (%): + 0.0249 (11.32)
Volume: 1,548,957 |
 |
Recent News
Inergetics Discovers Unique Combination of Cannabinoids for New Product Line as it Exits Phase II of R&D and Prepares for Final Development Phase
Breakthrough Further Illustrates Inergetics' Position as Nutraceutical Innovator
NEWARK, N.J., Sept. 24, 2014 /PRNewswire/ - Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements, today announced that it has identified and procured a non-cannabis source of an important cannabinoid that will be incorporated into its initial “first to market” combination cannabinoid product line to provide additional synergistic benefits in terms of overall efficacy and absorption.
“With direction from our Scientific/Medical Advisory Board and strategic relationships we have developed internationally, Inergetics has sourced and procured a novel non-cannabis cannabinoid to work side-by-side with CBD,” states Chief Science Officer Carl Germano, RD, CNS, CDN. “This additional cannabinoid from a non-cannabis source is a perfect companion to our CBD ingredient as it targets receptors in the body that help control inflammation and pain signaling. By bringing these two important cannabinoids together, our first nutraceutical CBD product line is capable of feeding the body’s own endocannabinoid system while delivering greater efficacy and helping to enhance absorption.”
“I’m pleased that our R&D efforts in cannabinoid science have led us to this unique and promising combination of phytocannabinoids that we expect will offer effective treatment for various pain-related ailments,” states Michael James, CEO of Inergetics. “Our team continues to research various CBD-related formulas and we are confident our research will continue to yield exciting results that we can bring to the market to address a wide array of symptoms.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
